Central proopiomelanocortin but not neuropeptide y mediates sympathoexcitation and hypertension in fat fed conscious rabbits

Journal of Hypertension

Volumn 34, Issue 3, 2016, Pages 464-473

  Barzel, Benjamin ^a,b   Lim, Kyungjoon ^a   Davern, Pamela J ^a   Burke, Sandra L ^a   Armitage, James A ^a,b,c   Head, Geoffrey A ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

Author keywords

hypertension; leptin; neuropeptide Y; obesity; renal sympathetic nerve activity; melanocortin stimulating hormone

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; LEPTIN; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR; PROOPIOMELANOCORTIN; PROTEIN C FOS; ALPHA INTERMEDIN; HORMONE; INTERMEDIN; MELANOCORTIN 2 RECEPTOR; MELANOCORTIN RECEPTOR; NEUROPEPTIDE Y; NEUROPEPTIDE Y-Y1 RECEPTOR;

ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BODY FAT; BRAIN LEVEL; CARDIOVASCULAR SYSTEM; COMPARATIVE STUDY; CONSCIOUSNESS; CONTROLLED STUDY; FAT INTAKE; HEART RATE; HYPERTENSION; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; KIDNEY NERVE; LIPID DIET; MALE; NEUROMODULATION; NEW ZEALAND WHITE (RABBIT); NONHUMAN; OBESITY; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RENAL SYMPATHETIC NERVE ACTIVITY; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE CELL; TELEMETRY; WHITE ADIPOSE TISSUE; ADRENERGIC SYSTEM; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; INNERVATION; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; RABBIT;

ALPHA-MSH; ANIMALS; BLOOD PRESSURE; BRAIN-DERIVED NEUROTROPHIC FACTOR; DIET, HIGH-FAT; HEART RATE; HORMONES; HYPERTENSION; HYPOTHALAMUS; KIDNEY; LEPTIN; MALE; MELANOCYTE-STIMULATING HORMONES; NEUROPEPTIDE Y; OBESITY; PRO-OPIOMELANOCORTIN; RABBITS; RECEPTORS, CORTICOTROPIN; RECEPTORS, MELANOCORTIN; RECEPTORS, NEUROPEPTIDE Y; SYMPATHETIC NERVOUS SYSTEM;

EID: 84957542130     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000811     Document Type: Article

References (47)

1. Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW, et al. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med 2003; 254:555-563.
2. Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 2011; 34:1481-1486.
3. Eikelis N, Esler M. The neurobiology of human obesity. Exp Physiol 2005; 90:673-682.
4. Mark AL. Selective leptin resistance revisited. Am J Physiol Regul Integr Comp Physiol 2013; 305:R566-R581.
5. Prior L, Eikelis N, Armitage J, Davern P, Burke S, Montani J-P, et al. Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension 2010; 55:862-868.
6. Lohmeier TE, Iliescu R, Liu B, Henegar JR, Maric-Bilkan C, Irwin ED. Systemic and renal-specific sympathoinhibition in obesity hypertension. Hypertension 2012; 59:331-338.
7. Antic V, Kiener-Belforti F, Tempini A, Van Vliet BN, Montani JP. Role of the sympathetic nervous system during the development of obesityinduced hypertension in rabbits. Am J Hypertens 2000; 13:556-559.
8. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334:292-295.
9. Lambert E, Ika Sari C, Hering D, Head GA, Straznicky N, Dixon JB, et al. Dyslipidemia is associated with sympathetic nervous activation and impaired endothelial function in young females. Am J Hypertens 2013; 26:250-256.
10. Matsumura K, Abe I, Tsuchihashi T, Fujishima M. Central effects of leptin on cardiovascular and neurohormonal responses in conscious rabbits. Am J Physiol Regul Integr Comp Physiol 2000; 278:R1314-R1320.
11. Dunbar JC, Hu Y, Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 1997; 46:2040-2043.
12. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptormediated regional sympathetic nerve activation by leptin. J Clin Invest 1997; 100:270-278.
13. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31:409-414.
14. Carlyle M, Jones OB, Kuo JJ, Hall JE. Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension 2002; 39:496-501.
15. Baltatzi M, Hatzitolios A, Tziomalos K, Iliadis F, Zamboulis C. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension. Int J Clin Pract 2008; 62:1432-1440.
16. Williams G, Bing C, Cai XJ, Harrold JA, King PJ, Liu XH. The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiol Behav 2001; 74:683-701.
17. Armitage JA, Burke SL, Prior LJ, Barzel B, Eikelis N, Lim K, et al. Rapid onset of renal sympathetic nerve activation in rabbits fed a high-fat diet. Hypertension 2012; 60:163-171.
18. Correia ML, Haynes WG, Rahmouni K, Morgan DA, Sivitz WI, Mark AL. The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 2002; 51:439-442.
19. Lim K, Burke SL, Head GA. Obesity related hypertension and the role of insulin and leptin in high fat fed rabbits. Hypertension 2013; 61:628-634.
20. Toda C, Shiuchi T, Kageyama H, Okamoto S, Coutinho EA, Sato T, et al. Extracellular signal-regulated kinase in the ventromedial hypothalamus mediates leptin-induced glucose uptake in red-type skeletal muscle. Diabetes 2013; 62:2295-2307.
21. Head GA, Williams NS. Hemodynamic effects of central angiotensin I, II and III in conscious rabbits. Am J Physiol Regul Integr Comp Physiol 1992; 263:R845-R851.
22. Burke SL, Evans RG, Head GA. Effects of chronic sympatho-inhibition on reflex control of renal blood flow and plasma renin activity in renovascular hypertension. Br J Pharmacol 2010; 159:438-448.
23. Dorward PK, Riedel W, Burke SL, Gipps J, Korner PI. The renal sympathetic baroreflex in the rabbit. Arterial and cardiac baroreceptor influences, resetting, and effect of anesthesia. Circ Res 1985; 57:618-633.
24. Lim K, Burke SL, Armitage JA, Head GA. Comparison of blood pressure and sympathetic activity of rabbits in their home cage and the laboratory environment. Exp Physiol 2012; 97:1263-1271.
25. Davern PJ, Head GA. Fos-related antigen immunoreactivity after acute and chronic angiotensin II-induced hypertension in the rabbit brain. Hypertension 2007; 49:1170-1177.
26. Burke SL, Head GA. Method for in vivo calibration of renal sympathetic nerve activity in rabbits. J Neurosci Meth 2003; 127:63-74.
27. Guild SJ, Barrett CJ, McBryde FD, Van Vliet BN, Head GA, Burke SL, et al. Quantifying sympathetic nerve activity; problems and pitfalls, the need for standardization. Exp Physiol 2010; 95:41-50.
28. Burke SL, Lambert E, Head GA. New approaches to quantifying sympathetic nerve activity. Curr Hypertens Rep 2011; 13:249-257.
29. da Silva AA, Kuo JJ, Tallam LS, Liu J, Hall JE. Does obesity induce resistance to the long-term cardiovascular and metabolic actions of melanocortin 3/4 receptor activation? Hypertension 2006; 47:259-264.
30. do Carmo JM, da Silva AA, Rushing JS, Hall JE. Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 2012; 302:R561-R567.
31. Dubinion JH, da Silva AA, Hall JE. Enhanced blood pressure and appetite responses to chronic central melanocortin-3/4 receptor blockade in dietary-induced obesity. J Hypertens 2010; 28:1466-1470.
32. Michaels S, Eppel GA, Burke SL, Head GA, Armitage JA, Carroll JF, et al. Altered responsiveness of the kidney to activation of the renal nerves in fat-fed rabbits. Am J Physiol Regul Integr Comp Physiol 2009; 296:R1889-R1896.
33. Eikelis N, Wiesner G, Lambert G, Esler M. Brain leptin resistance in human obesity revisited. Regul Pept 2007; 139:45-51.
34. Xin X, Storlien LH, Huang XF. Hypothalamic c-fos-like immunoreactivity in high-fat diet-induced obese and resistant mice. Brain Res Bull 2000; 52:235-242.
35. Caruso V, Lagerstrom MC, Olszewski PK, Fredriksson R, Schioth HB. Synaptic changes induced by melanocortin signalling. Nat Rev Neurosci 2014; 15:98-110.
36. Unger TJ, Calderon GA, Bradley LC, Sena-Esteves M, Rios M. Selective deletion of BDNF in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity. J Neurosci 2007; 27:14265-14274.
37. Haynes WG, Morgan DA, Djalali A, Sivitz WI, Mark AL. Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 1999; 33:542-547.
38. Goldsmith SR, Sobotka PA, Bart BA. The sympathorenal axis in hypertension and heart failure. J Card Fail 2010; 16:369-373.
39. Lu H, Buison A, Jen KC, Dunbar JC. Leptin resistance in obesity is characterized by decreased sensitivity to proopiomelanocortin products. Peptides 2000; 21:1479-1485.
40. Guan XM, Yu H, Trumbauer M, Frazier E, Van der Ploeg LH, Chen H. Induction of neuropeptide Y expression in dorsomedial hypothalamus of diet-induced obese mice. Neuroreport 1998; 9:3415-3419.
41. Chao PT, Yang L, Aja S, Moran TH, Bi S. Knockdown of NPY expression in the dorsomedial hypothalamus promotes development of brown adipocytes and prevents diet-induced obesity. Cell Metab 2011; 13:573-583.
42. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996; 45:531-535.
43. Roseberry AG, Liu H, Jackson AC, Cai X, Friedman JM. Neuropeptide Ymediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice. Neuron 2004; 41:711-722.
44. Cassaglia PA, Shi Z, Li B, Reis WL, Clute-Reinig NM, Stern JE, et al. Neuropeptide Y acts in the paraventricular nucleus to suppress sympathetic nerve activity and its baroreflex regulation. J Physiol 2014; 592:1655-1675.
45. Shi Z, Li B, Brooks VL. Role of the paraventricular nucleus of the hypothalamus in the sympathoexcitatory effects of leptin. Hypertension 2015; 66:1034-1041.
46. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 1994; 8:1298-1308.
47. Lindberg D, Chen P, Li C. Conditional viral tracing reveals that steroidogenic factor 1-positive neurons of the dorsomedial subdivision of the ventromedial hypothalamus project to autonomic centers of the hypothalamus and hindbrain. J Comp Neurol 2013; 521:3167-3190.